Expert opinion
Successful intervention with B vitamins to help prevent mild cognitive impairment is shown to be enhanced by a superior marine omega-3 fatty acid status
15 February 2016
Professor Celeste de Jager of the Division of Geriatric Medicine at the University of Cape Town, South Africa, specializes in the effect of nutrition on cognitive decline in the elderly. In recent years, she has been closely involved in the VITACOG randomized controlled trial which found that a vitamin B intervention reduced circulating homocysteine levels, leading to a reduced rate of cognitive decline. Her most recent paper demonstrates that this effect is dependent on the patient having omega-3 fatty acid levels in the upper-normal range.